Clinical Trial Update: A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing three-study medicines (encorafenib, binimetinib, pembrolizumab) to two-study medicines (ipilimumab and nivolumab) in patients with adv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Binimetinib (binimetinib)
• Encorafenib (encorafenib)
• Pembrolizumab (pembrolizumab)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Pfizer | Conditions: Melanoma | Phase 2 | Status: TERMINATED